So those were the two points that Mr Watts raised, and then turning now to Ms van Velden, she's made an assertion that nothing really has changed. Actually, a lot has changed. That might be her cursory reading of things, but the reality is that following the interim report, which really highlighted Pharmac's inability to perform well when it comes to equity, it was at that point that, given the health sector principles, and the legislation was in the House by that time, it was pretty clear that we could actually address that by bringing Pharmac into the rubric of health entities, which the select committee subsequently did, and I was very supportive of that. So that happened. That will make a significant difference—just requiring Pharmac to satisfy those health sector principles will make a significant difference. So I'm sure that it will.